News
$Cadrenal Therapeutics(CVKD.US$ Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts
3 MINUTES AGO, 9:00 AM EDT
VIA PR NEWSWIRE
3 MINUTES AGO, 9:00 AM EDT
VIA PR NEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment